Who owns Quoin Pharmaceuticals Ltd ADR?
- Ticker: QNRX
- CUSIP Number: 74907l409
Tip: Access positions for across all investors
Analyze quarterly positions in Quoin Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Quoin Pharmaceuticals stock
Who bought or sold Quoin Pharmaceuticals Ltd ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 212k | $1.4M | 0% | Mar 2026 |
|
| SummitTX Capital | 100k | $662k | 55% | Mar 2026 |
|
| Woodline Partners | 80k | $525k | 0% | Mar 2026 |
|
| Stonepine Capital Management | 78k | $1.1M | 100% | Dec 2025 |
|
| Millennium Management | 76k | $503k | 2% | Mar 2026 |
|
| Standard Life Aberdeen | 75k | $495k | 0% | Mar 2026 |
|
| Soleus Capital Management | 73k | $480k | 191% | Mar 2026 |
|
| Centiva Capital | 60k | $396k | 398% | Mar 2026 |
|
| Boothbay Fund Management | 60k | $395k | 0% | Mar 2026 |
|
| AIGH Capital Management | 51k | $337k | 3% | Mar 2026 |
|
| Citadel Advisors | 33k | $215k | 100% | Mar 2026 |
|
| Birchview Capital | 20k | $132k | 100% | Mar 2026 |
|
| Morgan Stanley | 4.0k | $26k | 100% | Mar 2026 |
|
| UBS Group | 2.5k | $17k | 14676% | Mar 2026 |
|
| GAMMA Investing | 1.7k | $11k | -17% | Mar 2026 |
|
| Rhumbline Advisers | 1.5k | $10k | -9% | Mar 2026 |
|
| Royal Bank of Canada | 11.00 | $0 | 100% | Mar 2026 |
|
| SBI Securities | 2.00 | $13.000000 | -99% | Mar 2026 |
|
Who sold out of Quoin Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| ADAR1 Capital Management | Dec 2025 | 58k | $840k |
| Resolute Capital Asset Partners | Dec 2025 | 30k | $433k |
| Simplify Asset Management | Dec 2025 | 17k | $252k |